Cosopt PF Interactions
There are 291 drugs known to interact with Cosopt PF (dorzolamide/timolol ophthalmic), along with 16 disease interactions. Of the total drug interactions, 37 are major, 250 are moderate, and 4 are minor.
- View all 291 medications that may interact with Cosopt PF
- View Cosopt PF disease interactions (16)
Most frequently checked interactions
View interaction reports for Cosopt PF (dorzolamide / timolol ophthalmic) and the medicines listed below.
- acetaminophen
- acetazolamide
- albuterol
- allopurinol
- Alphagan P (brimonidine ophthalmic)
- amlodipine
- amoxicillin
- aspirin
- atorvastatin
- clopidogrel
- doxycycline
- Eliquis (apixaban)
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- latanoprost ophthalmic
- levothyroxine
- lisinopril
- Lumigan (bimatoprost ophthalmic)
- metformin
- Metoprolol Succinate ER (metoprolol)
- Myrbetriq (mirabegron)
- omeprazole
- pantoprazole
- simvastatin
- tamsulosin
- trazodone
- Vitamin D3 (cholecalciferol)
- Zioptan (tafluprost ophthalmic)
Cosopt PF disease interactions
There are 16 disease interactions with Cosopt PF (dorzolamide / timolol ophthalmic) which include:
- asthma/COPD
- bradycardia/AV block
- cardiogenic shock
- CHF
- diabetes
- hypersensitivity
- hyperthyroidism
- PVD
- hematologic toxicity
- hypersensitivity reactions
- porphyria
- myasthenia gravis
- crystalluria
- liver disease
- renal dysfunction
- urinary obstruction
Report options
QR code containing a link to this page
More about Cosopt PF (dorzolamide / timolol ophthalmic)
- Cosopt PF consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: ophthalmic glaucoma agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.